240 related articles for article (PubMed ID: 11591435)
1. Human metabolism of phytanic acid and pristanic acid.
Verhoeven NM; Jakobs C
Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
[TBL] [Abstract][Full Text] [Related]
2. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of phytanic acid and pristanic acid in man: a review.
Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
[TBL] [Abstract][Full Text] [Related]
4. The chemical biology of branched-chain lipid metabolism.
Mukherji M; Schofield CJ; Wierzbicki AS; Jansen GA; Wanders RJ; Lloyd MD
Prog Lipid Res; 2003 Sep; 42(5):359-76. PubMed ID: 12814641
[TBL] [Abstract][Full Text] [Related]
5. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
[TBL] [Abstract][Full Text] [Related]
6. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
7. Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts.
Verhoeven NM; Roe DS; Kok RM; Wanders RJ; Jakobs C; Roe CR
J Lipid Res; 1998 Jan; 39(1):66-74. PubMed ID: 9469587
[TBL] [Abstract][Full Text] [Related]
8. Phytanic acid metabolism in health and disease.
Wanders RJ; Komen J; Ferdinandusse S
Biochim Biophys Acta; 2011 Sep; 1811(9):498-507. PubMed ID: 21683154
[TBL] [Abstract][Full Text] [Related]
9. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.
Van Veldhoven PP
J Lipid Res; 2010 Oct; 51(10):2863-95. PubMed ID: 20558530
[TBL] [Abstract][Full Text] [Related]
10. Phytanic acid: production from phytol, its breakdown and role in human disease.
van den Brink DM; Wanders RJ
Cell Mol Life Sci; 2006 Aug; 63(15):1752-65. PubMed ID: 16799769
[TBL] [Abstract][Full Text] [Related]
11. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
[TBL] [Abstract][Full Text] [Related]
12. Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.
Singh H; Beckman K; Poulos A
J Biol Chem; 1994 Apr; 269(13):9514-20. PubMed ID: 8144536
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
Poulos A; Sharp P; Fellenberg AJ; Johnson DW
Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
[TBL] [Abstract][Full Text] [Related]
14. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
Kruska N; Reiser G
Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
[TBL] [Abstract][Full Text] [Related]
15. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
Wanders RJ; Komen JC
Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
[TBL] [Abstract][Full Text] [Related]
16. Intraorganellar localization of CoASH-independent phytanic acid oxidation in human liver peroxisomes.
Pahan K; Singh I
FEBS Lett; 1993 Oct; 333(1-2):154-8. PubMed ID: 8224157
[TBL] [Abstract][Full Text] [Related]
17. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
18. Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
Kase BF; Björkhem I
Scand J Clin Lab Invest; 1996 May; 56(3):211-7. PubMed ID: 8761525
[TBL] [Abstract][Full Text] [Related]
19. Alpha-oxidation.
Jansen GA; Wanders RJ
Biochim Biophys Acta; 2006 Dec; 1763(12):1403-12. PubMed ID: 16934890
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomes contain a specific phytanoyl-CoA/pristanoyl-CoA thioesterase acting as a novel auxiliary enzyme in alpha- and beta-oxidation of methyl-branched fatty acids in mouse.
Westin MAK; Hunt MC; Alexson SEH
J Biol Chem; 2007 Sep; 282(37):26707-26716. PubMed ID: 17613526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
